guidelines for the drug formulary in next year's Medicare
prescription drug benefit could force patients to pay out
of pocket for expensive drugs. The American Medical Association,
the American College of Physicians and other groups raised
concerns that the U.S. Pharmacopeial Convention's recommendations
contain too few categories of drugs that are thus too broad.
Drug plans must cover two drugs in each "class"
of medicines to gain Medicare approval.